Literature DB >> 35333965

Non-stenting treatment versus endoscopic stent placement in staple line leaks after laparoscopic sleeve gastrectomy.

Andreas Kiriakopoulos1, Nefeli Kounatidis2, Ilias Menenakos3, Maria Kostrova3, Konstantinos Zografos2, Evangelos Menenakos2,4.   

Abstract

PURPOSE: Presentation of results of non-stenting treatment versus endoscopic stenting placement in gastric staple leaks after laparoscopic sleeve gastrectomy (LSG).
METHODS: Between January 2007 and August 2020, 1371 eligible patients underwent LSG. After gastric leak detection, patients were classified into treatment groups A (endoscopic stent placement) and B (non-stenting management). Overall hospital stay, the time to complete gastric leak resolution and the incidence of further operative management constituted the main outcome measures. Statistical analysis included descriptive statistics and linear regression tests as needed.
RESULTS: A total of 27 patients (19 F/8 M, median age: 44.8 years (range: 36-58) with median preoperative BMI: 43.5 kg/m2 (range: 37.0-48.7)) presented with gastric staple line leak (1.9%) - mean detection day 5.8 postop (range: 1-12). Eight patients enrolled in group A and 19 patients in group B. The mean hospital stay for group A was 41.2 days (range: 24-60) versus 15 days (range: 12-18) for group B (p < 0.001). Complete leakage resolution was observed at mean 42.4 days (range 25-60) for group A and 34.5 days (range: 28-40) for group B patients, (p = 0.025). Only 2 group A patients accomplished complete leak resolution without additional intervention. Five group A patients (62.5%) versus 4 group B patients (21.1%) needed operative intervention during the treatment course (p = 0.037).
CONCLUSIONS: Conservative, non-stenting treatment of staple line leaks after LSG is feasible and is associated with superior results in terms of hospital say and leak resolution in comparison to endoscopic stenting.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bariatric surgery; Gastric staple line leak; Laparoscopic sleeve gastrectomy; Stents

Mesh:

Year:  2022        PMID: 35333965     DOI: 10.1007/s00423-022-02498-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  15 in total

Review 1.  Reinforcement does not necessarily reduce the rate of staple line leaks after sleeve gastrectomy. A review of the literature and clinical experiences.

Authors:  Bo Chen; Andreas Kiriakopoulos; Dimitrios Tsakayannis; Mitchell S Wachtel; Dimitrios Linos; Eldo E Frezza
Journal:  Obes Surg       Date:  2008-09-16       Impact factor: 4.129

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 3.  Comparison of laparoscopic sleeve gastrectomy leak rates in four staple-line reinforcement options: a systematic review.

Authors:  Michel Gagner; Jane N Buchwald
Journal:  Surg Obes Relat Dis       Date:  2014-01-28       Impact factor: 4.734

4.  Fifth International Consensus Conference: current status of sleeve gastrectomy.

Authors:  Michel Gagner; Colleen Hutchinson; Raul Rosenthal
Journal:  Surg Obes Relat Dis       Date:  2016-01-25       Impact factor: 4.734

5.  Reoperative surgery for nonresponders and complicated sleeve gastrectomy operations in patients with severe obesity. An international expert panel consensus statement to define best practice guidelines.

Authors:  Kandace Kichler; Raul J Rosenthal; Eric DeMaria; Kelvin Higa
Journal:  Surg Obes Relat Dis       Date:  2018-11-15       Impact factor: 4.734

6.  Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.

Authors:  Piotr Kalinowski; Rafał Paluszkiewicz; Tadeusz Wróblewski; Piotr Remiszewski; Mariusz Grodzicki; Zbigniew Bartoszewicz; Marek Krawczyk
Journal:  Surg Obes Relat Dis       Date:  2016-08-18       Impact factor: 4.734

Review 7.  Identifying Patients With Sepsis on the Hospital Wards.

Authors:  Poushali Bhattacharjee; Dana P Edelson; Matthew M Churpek
Journal:  Chest       Date:  2016-07-01       Impact factor: 9.410

8.  Long-Term Changes in Leptin, Chemerin, and Ghrelin Levels Following Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy.

Authors:  Mohamed Abdalla Salman; Mohamed El-Ghobary; Ahmed Soliman; Mohammad El Sherbiny; Tarek Elsayed Abouelregal; Amr Albitar; Ahmed Abdallah; Hani Maurice Sabri Mikhail; Mohammed A Nafea; Ahmed Abd El Aal Sultan; Hossam E Elshafey; Hossam El-Din Shaaban; Ayman Azzam; Ghada M K GabAllah; Ahmed Abdallah Salman
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

9.  IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.

Authors:  Luigi Angrisani; A Santonicola; P Iovino; A Vitiello; K Higa; J Himpens; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

10.  Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.

Authors:  Kathleen M McTigue; Robert Wellman; Elizabeth Nauman; Jane Anau; R Yates Coley; Alberto Odor; Julie Tice; Karen J Coleman; Anita Courcoulas; Roy E Pardee; Sengwee Toh; Cheri D Janning; Neely Williams; Andrea Cook; Jessica L Sturtevant; Casie Horgan; David Arterburn
Journal:  JAMA Surg       Date:  2020-05-20       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.